TP53 and esophageal squamous cell carcinoma: AGR2 is overexpressed in esophageal squamous cell carcinoma and that AGR2 expression may serve as a biomarker for predicting the response to treatment in esophageal squamous cell carcinoma and as a potential therapeutic target for patients with P53 wild-type esophageal squamous cell carcinoma [90,144].